Psychedelic-assisted therapy combines carefully supervised psychedelic sessions with structured psychological and physical preparation + integration before and after. At INLIBRIUM it is one component of a six-month program — not the product itself. Each residency includes two professionally facilitated sessions embedded in months of psychotherapy, health work and executive coaching. The experience opens a door; the months of integration around it are what create lasting change.
The three residencies take place at our private site in Jamaica, where psilocybin, the active compound in magic mushrooms, is not a prohibited substance and psychedelic-assisted work can be conducted openly and legally. The rest of the six-month program — preparation, testing, integration and coaching — happens online, wherever you are.
The program is built for founders, CEOs and senior leaders who have won the external game but are quietly asking “Is this it?” It is not for anyone seeking a quick fix, a weekend breakthrough or an escape. It demands time, honesty and real work over six months. If you want a feel-good retreat, this isn’t it. If you’re ready to do the work, it may be.
Every client passes a two-part eligibility assessment before acceptance: a psychiatric screening that rules out contraindications for psychedelic therapy, and a medical review covering bloodwork, cardiovascular and renal markers, blood pressure, history and medications. During residencies you are supported by a team of 4–5 experts, with two facilitators present in every psychedelic session and 24/7 staff on site.
Six months, in three phases. Each one anchored by a seven-day residency in Jamaica, one client at a time.
Phase one · months 1–2. Begins in week one, before you travel: founder calls, psychiatric and medical eligibility assessment, then a full testing panel — DNA, gut health, hormones, metabolic markers, biological age — alongside psychotherapy, coaching and health consultations that prepare you for the work. It closes with your first residency and the weeks of structured integration that follow it.
Phase two · months 3–4. Your second residency and the integration around it: weekly psychotherapy and health calls, coaching every second week.
Phase three · months 5–6. Your third residency and the integration that follows it, then consolidation — the full diagnostic panel measured again, and a final meeting with the founders.
A retreat gives you only an experience; we build the sustainable transformation around it. You cannot resolve a lifetime of patterns in a weekend — the breakthrough that isn’t integrated wears off in months. INLIBRIUM surrounds every psychedelic session with hundreds of hours of 1:1 work from a dedicated psychiatrist or psychologist, health expert and executive/conscious leadership coach across six months. The door is not the destination. Integration is everything.
Fully, in an unprecedentedly individualized format. There is no one-size-fits-all standardized protocol, path or dose. Your program is designed around your psychiatric and medical assessment, your full diagnostic panel (DNA, hormones, metabolic and biological-age testing) and your goals. Three core experts work with you throughout: a personal psychiatrist/psychologist, a personal health expert and a personal Conscious Leadership coach — supported by additional specialists during your three private residencies.
Discretion is structural and formalized, not just promised. We work with a small number of clients per year, residencies are private — one client at a time, with a dedicated staff of seven — and contracts include strict confidentiality. Client stories are published only with explicit written consent. Many of our clients are public figures; protecting their privacy is a precondition of the work, not an afterthought.
A growing body of clinical research — including trials at Johns Hopkins and Imperial College London, published in The New England Journal of Medicine — shows that psilocybin-assisted therapy, combined with preparation and integration, can reduce symptoms of depression and anxiety for weeks to months. Longer-term results are still being studied. A 2025 study in Nature’s npj Aging found that psilocybin’s active form extended the lifespan of human cells in a dish and that psilocybin improved survival in aged mice. It has not been studied for aging in people. Our clinical leads have decades of experience in psychedelic research and clinical trials. We don’t promise magic: we apply evidence, screening and structure to work that research increasingly supports.
Further reading (independent articles, not about INLIBRIUM): Harvard Business Review — Will Psychedelics Propel Your Career? · Forbes — Psychedelic Therapy Could Redefine Career Mental Health
They make the program measurable instead of anecdotal. Before your first residency we map your baseline: DNA, gut health, hormone panel, metabolic markers, biological age, fatty-acid index and heavy metals, plus continuous biometric tracking. Your personal health expert uses this data to build your personalized lifestyle (including nutrition, sleep and recovery) protocols — and to measure what actually changed by the end of the program.
The goal is not just lifespan but healthspan: bio-individual biomarker optimization so you don’t only live longer — you live and lead better.
No. Most of our clients come with little or no experience — what matters is psychological and medical eligibility, which we assess before acceptance. Preparation sessions build understanding and readiness long before the first residency, and every session is guided by two experienced facilitators. Prior experience is neither required nor an advantage; readiness to do honest work is.
They are different tools, and neither is better in general. Ketamine is an anesthetic that acts on the brain's glutamate system. A nasal form, esketamine, was approved by the FDA in 2019 for treatment-resistant depression, and clinics also give ketamine off-label by infusion, usually as a series of sessions over a few weeks. A session lasts an hour or two, the lift in mood can come quickly, and it often fades, so repeat sessions are common.
Psilocybin acts mainly on serotonin receptors. A session lasts six hours or more, and in the clinical trials for depression people received one or two sessions with psychological preparation before and integration after.
INLIBRIUM's residencies use psilocybin, because the aim is not relief between sessions but a change you build on over six months — and psilocybin has been studied in that shape: few sessions, careful preparation, long integration. If what you are looking for is treatment for depression, the choice between the two belongs with a psychiatrist.
Coaching is one part of it, not the whole. Your Conscious Leadership coach works with you for the full six months, alongside your psychiatrist or psychologist and your health expert. The psychedelic sessions happen during the three residencies, with two facilitators and medical oversight. The coaching is where what surfaced in them turns into decisions: how you lead, what you stop carrying, what you build next.
Coaching on its own has good evidence with working leaders. In a randomized trial, ten weekly one-to-one sessions reduced all three dimensions of burnout in 92 managers (Frontiers in Psychology, 2023). No trial has tested coaching combined with psychedelic-assisted sessions, and we will not claim otherwise. The full evidence is on our research page.
Not in the usual sense. Most of our clients already perform. What brings them is that success stopped feeling like enough — the question on our home page, “Is this it?” The program works on the person underneath the performance: psychological work, health measured by biomarkers, and leadership coaching over six months. Performance can follow, and we measure sleep, recovery and biomarkers before and after, but it is a consequence, not the promise. If you are looking for a short performance protocol, this is probably not the right fit.
The evidence is narrower than the marketing. Psilocybin-assisted therapy has been studied mostly in depression. Burnout itself has been measured in only a few small trials, all in frontline healthcare workers rather than executives. What the wider research supports is that burnout at this level rarely responds to one change: it shows up in thinking, mood, relationships, the body and meaning at once, and combined approaches do better than single ones (Lancet, 2016). That is why psilocybin sessions are one part of six months of psychological, health and leadership work at INLIBRIUM, and why screening comes first. If low mood runs across your whole life, not only your work, have it assessed by a professional first.
It begins with a private conversation with the founders — an unhurried call to understand where you are, what you’re looking for, and whether there is mutual fit. No pitch, no pressure; we accept a limited number of clients per year and mutual fit matters more to us than filling places. If we both feel it’s right, the eligibility assessment follows. Pricing is discussed in that first conversation.